Yarrow Bioscience, Inc. (YARW)
40.85
+1.60
(+4.08%)
USD |
NASDAQ |
Aug 26, 12:09
Yarrow Bioscience Total Assets (Quarterly) : 23.60M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 23.60M |
| March 31, 2026 | 25.87M |
| December 31, 2025 | 30.16M |
| September 30, 2025 | 36.13M |
| June 30, 2025 | 44.72M |
| March 31, 2025 | 56.42M |
| December 31, 2024 | 66.90M |
| September 30, 2024 | 76.20M |
| June 30, 2024 | 86.65M |
| March 31, 2024 | 91.68M |
| December 31, 2023 | 97.68M |
| September 30, 2023 | 19.27M |
| June 30, 2023 | 24.96M |
| March 31, 2023 | 35.26M |
| December 31, 2022 | 40.76M |
| September 30, 2022 | 46.91M |
| June 30, 2022 | 55.19M |
| March 31, 2022 | 64.32M |
| December 31, 2021 | 67.05M |
| September 30, 2021 | 81.32M |
| Date | Value |
|---|---|
| June 30, 2021 | 133.98M |
| March 31, 2021 | 149.17M |
| December 31, 2020 | 93.74M |
| September 30, 2020 | 107.68M |
| June 30, 2020 | 130.84M |
| March 31, 2020 | 160.53M |
| December 31, 2019 | 81.16M |
| September 30, 2019 | 96.58M |
| June 30, 2019 | 114.38M |
| March 31, 2019 | 126.26M |
| December 31, 2018 | 139.93M |
| September 30, 2018 | 154.96M |
| June 30, 2018 | 166.92M |
| March 31, 2018 | 180.48M |
| December 31, 2017 | 66.87M |
| September 30, 2017 | 75.80M |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | 42.05M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Oramed Pharmaceuticals, Inc. | 369.64M |
| NRX Pharmaceuticals, Inc. | 34.16M |
| ANI Pharmaceuticals, Inc. | 1.494B |
| Corcept Therapeutics, Inc. | 888.70M |
| Veru, Inc. | 37.03M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.542M |
| Shareholders Equity (Quarterly) | 22.06M |
| Current Ratio | 15.26 |
| Net Debt Paydown Yield | 0.06% |